Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 01)
Fosinopril Sodium Tablet
Product Images NDC 71335-0187
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium (NDC 71335-0187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 02)
This text shows the incidence of clinical adverse events in placebo-controlled trials for hypertension with Fosinopril Sodium and Placebo. The table includes the number of participants for each group (688 for Fosinopril Sodium and 184 for placebo), and the incidence of adverse events such as cough, dizziness, nausea and vomiting, as well as the number of participants who discontinued the trial due to these adverse events.*
Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 03)
Label Image (Lbl713350187)
This is a description of a medication containing Fosinopril and Sodium used for treating cardiovascular diseases. The medication is in form of a round, white tablet with imprint code 1G;201, and it comes in a package of 30 tablets. The medication should be stored at room temperature, between 20°C-25°C (68°F-77°F), and kept out of reach of children. The medication is manufactured by InvaGen Pharmaceuticals, Inc., and its NDC code is 7133501871 06994301523487.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
